Antithrombotic Prophylaxis No Help in Outpatients With COVID

(MedPage Today) -- The routine use of antithrombotic therapies to prevent thromboembolic complications provided no benefit for symptomatic outpatients with COVID-19, according to the results of two randomized trials. In the OVID trial, the 30...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news